Loading…

Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis

Diabetes mellitus (DM) is a chronic inflammatory disease, and the rapidly increasing DM is becoming a major problem of global public health. Traditional Chinese medicine (TCM) has a long history of treating diabetes. It has been developed and utilized because of its good efficacy and no toxic side e...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2020-03, Vol.11, p.347-347
Main Authors: Ge, Qi, Chen, Liang, Yuan, Yi, Liu, Lanlan, Feng, Fan, Lv, Peng, Ma, Shangshang, Chen, Keping, Yao, Qin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c462t-cea87316b16f8aa9495eeee1ea15c51735f1ab1729da9b533f82ed6b9eb464bd3
cites cdi_FETCH-LOGICAL-c462t-cea87316b16f8aa9495eeee1ea15c51735f1ab1729da9b533f82ed6b9eb464bd3
container_end_page 347
container_issue
container_start_page 347
container_title Frontiers in pharmacology
container_volume 11
creator Ge, Qi
Chen, Liang
Yuan, Yi
Liu, Lanlan
Feng, Fan
Lv, Peng
Ma, Shangshang
Chen, Keping
Yao, Qin
description Diabetes mellitus (DM) is a chronic inflammatory disease, and the rapidly increasing DM is becoming a major problem of global public health. Traditional Chinese medicine (TCM) has a long history of treating diabetes. It has been developed and utilized because of its good efficacy and no toxic side effects. is a traditional whole grass herbal. With the continuous deepening of pharmacological research on TCM, the active ingredients of are continuously revealed, which contained the alkaloids, flavonoids, flavonoid glycosides and amino acids that have the good effects of anti-inflammatory, anti-viral and anti-diabetic. In order to further explore the targets of active ingredients and its anti-diabetic mechanism, a feasible network pharmacology analysis model based on chemical, pharmacokinetic and pharmacological data was developed by network construction method to clarify the anti-diabetic mechanism of . The present study conducted by gas chromatography-mass spectrometer (GC/MS), which identified 208 metabolites of , of which 23 ingredients may have effective pharmacological effects after absorption, distribution, metabolism, and excretion (ADME) screening. Network pharmacological analysis on the active ingredients revealed that 5-hydroxymethylfurfural in affects the insulin resistance signaling pathway by acting on GSK3B, TNF, and MAPK1, acacetin affects the diabetic pathway by acting on INSR, DPP4, and GSK3B, that regulate type 2 diabetes, non-insulin-dependent DM, and inflammatory diseases. These results successfully indicated the potential anti-diabetic mechanism of the active ingredients of .
doi_str_mv 10.3389/fphar.2020.00347
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_eff47db032e544e89c27ebeb98f8008a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_eff47db032e544e89c27ebeb98f8008a</doaj_id><sourcerecordid>2387691447</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-cea87316b16f8aa9495eeee1ea15c51735f1ab1729da9b533f82ed6b9eb464bd3</originalsourceid><addsrcrecordid>eNpVkUtv1DAQgCMEolXpnRPKkUsWv-LHBam0PCotjwMcOFljZ7xxSeLFzoL678nulqqdiy3PzDcjf1X1kpIV59q8Cdse8ooRRlaEcKGeVKdUSt4YTdnTB_eT6ryUG7IEN4ZL8bw64YzJVlF1Wv38gvPflH_V3xbYCD4NaXPbvIOCXX0VS0E_xzTVKdRzj_XFNMemi-Bwjr7-jL6HKZZxn14nh0OE2vdxwqnE8qJ6FmAoeH53nlU_Prz_fvmpWX_9eH15sW68kGxuPIJWnEpHZdAARpgWl6AItPUtVbwNFBxVzHRgXMt50Aw76Qw6IYXr-Fl1feR2CW7sNscR8q1NEO3hIeWNhbysO6DFEITqHOEMWyFQG88UOnRGB02IhoX19sja7tyIncdpzjA8gj7OTLG3m_THKmLM8qML4PUdIKffOyyzHWPxOAwwYdoVy7hW0lAh9qXkWOpzKiVjuB9Did0LtgfBdi_YHgQvLa8ernff8F8n_wc9iqRZ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2387691447</pqid></control><display><type>article</type><title>Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis</title><source>PubMed Central</source><creator>Ge, Qi ; Chen, Liang ; Yuan, Yi ; Liu, Lanlan ; Feng, Fan ; Lv, Peng ; Ma, Shangshang ; Chen, Keping ; Yao, Qin</creator><creatorcontrib>Ge, Qi ; Chen, Liang ; Yuan, Yi ; Liu, Lanlan ; Feng, Fan ; Lv, Peng ; Ma, Shangshang ; Chen, Keping ; Yao, Qin</creatorcontrib><description>Diabetes mellitus (DM) is a chronic inflammatory disease, and the rapidly increasing DM is becoming a major problem of global public health. Traditional Chinese medicine (TCM) has a long history of treating diabetes. It has been developed and utilized because of its good efficacy and no toxic side effects. is a traditional whole grass herbal. With the continuous deepening of pharmacological research on TCM, the active ingredients of are continuously revealed, which contained the alkaloids, flavonoids, flavonoid glycosides and amino acids that have the good effects of anti-inflammatory, anti-viral and anti-diabetic. In order to further explore the targets of active ingredients and its anti-diabetic mechanism, a feasible network pharmacology analysis model based on chemical, pharmacokinetic and pharmacological data was developed by network construction method to clarify the anti-diabetic mechanism of . The present study conducted by gas chromatography-mass spectrometer (GC/MS), which identified 208 metabolites of , of which 23 ingredients may have effective pharmacological effects after absorption, distribution, metabolism, and excretion (ADME) screening. Network pharmacological analysis on the active ingredients revealed that 5-hydroxymethylfurfural in affects the insulin resistance signaling pathway by acting on GSK3B, TNF, and MAPK1, acacetin affects the diabetic pathway by acting on INSR, DPP4, and GSK3B, that regulate type 2 diabetes, non-insulin-dependent DM, and inflammatory diseases. These results successfully indicated the potential anti-diabetic mechanism of the active ingredients of .</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2020.00347</identifier><identifier>PMID: 32265717</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>active ingredients ; anti-diabetic ; anti-inflammatory ; Lobelia chinensis ; network pharmacology ; Pharmacology</subject><ispartof>Frontiers in pharmacology, 2020-03, Vol.11, p.347-347</ispartof><rights>Copyright © 2020 Ge, Chen, Yuan, Liu, Feng, Lv, Ma, Chen and Yao.</rights><rights>Copyright © 2020 Ge, Chen, Yuan, Liu, Feng, Lv, Ma, Chen and Yao 2020 Ge, Chen, Yuan, Liu, Feng, Lv, Ma, Chen and Yao</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-cea87316b16f8aa9495eeee1ea15c51735f1ab1729da9b533f82ed6b9eb464bd3</citedby><cites>FETCH-LOGICAL-c462t-cea87316b16f8aa9495eeee1ea15c51735f1ab1729da9b533f82ed6b9eb464bd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099657/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099657/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32265717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ge, Qi</creatorcontrib><creatorcontrib>Chen, Liang</creatorcontrib><creatorcontrib>Yuan, Yi</creatorcontrib><creatorcontrib>Liu, Lanlan</creatorcontrib><creatorcontrib>Feng, Fan</creatorcontrib><creatorcontrib>Lv, Peng</creatorcontrib><creatorcontrib>Ma, Shangshang</creatorcontrib><creatorcontrib>Chen, Keping</creatorcontrib><creatorcontrib>Yao, Qin</creatorcontrib><title>Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis</title><title>Frontiers in pharmacology</title><addtitle>Front Pharmacol</addtitle><description>Diabetes mellitus (DM) is a chronic inflammatory disease, and the rapidly increasing DM is becoming a major problem of global public health. Traditional Chinese medicine (TCM) has a long history of treating diabetes. It has been developed and utilized because of its good efficacy and no toxic side effects. is a traditional whole grass herbal. With the continuous deepening of pharmacological research on TCM, the active ingredients of are continuously revealed, which contained the alkaloids, flavonoids, flavonoid glycosides and amino acids that have the good effects of anti-inflammatory, anti-viral and anti-diabetic. In order to further explore the targets of active ingredients and its anti-diabetic mechanism, a feasible network pharmacology analysis model based on chemical, pharmacokinetic and pharmacological data was developed by network construction method to clarify the anti-diabetic mechanism of . The present study conducted by gas chromatography-mass spectrometer (GC/MS), which identified 208 metabolites of , of which 23 ingredients may have effective pharmacological effects after absorption, distribution, metabolism, and excretion (ADME) screening. Network pharmacological analysis on the active ingredients revealed that 5-hydroxymethylfurfural in affects the insulin resistance signaling pathway by acting on GSK3B, TNF, and MAPK1, acacetin affects the diabetic pathway by acting on INSR, DPP4, and GSK3B, that regulate type 2 diabetes, non-insulin-dependent DM, and inflammatory diseases. These results successfully indicated the potential anti-diabetic mechanism of the active ingredients of .</description><subject>active ingredients</subject><subject>anti-diabetic</subject><subject>anti-inflammatory</subject><subject>Lobelia chinensis</subject><subject>network pharmacology</subject><subject>Pharmacology</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtv1DAQgCMEolXpnRPKkUsWv-LHBam0PCotjwMcOFljZ7xxSeLFzoL678nulqqdiy3PzDcjf1X1kpIV59q8Cdse8ooRRlaEcKGeVKdUSt4YTdnTB_eT6ryUG7IEN4ZL8bw64YzJVlF1Wv38gvPflH_V3xbYCD4NaXPbvIOCXX0VS0E_xzTVKdRzj_XFNMemi-Bwjr7-jL6HKZZxn14nh0OE2vdxwqnE8qJ6FmAoeH53nlU_Prz_fvmpWX_9eH15sW68kGxuPIJWnEpHZdAARpgWl6AItPUtVbwNFBxVzHRgXMt50Aw76Qw6IYXr-Fl1feR2CW7sNscR8q1NEO3hIeWNhbysO6DFEITqHOEMWyFQG88UOnRGB02IhoX19sja7tyIncdpzjA8gj7OTLG3m_THKmLM8qML4PUdIKffOyyzHWPxOAwwYdoVy7hW0lAh9qXkWOpzKiVjuB9Did0LtgfBdi_YHgQvLa8ernff8F8n_wc9iqRZ</recordid><startdate>20200320</startdate><enddate>20200320</enddate><creator>Ge, Qi</creator><creator>Chen, Liang</creator><creator>Yuan, Yi</creator><creator>Liu, Lanlan</creator><creator>Feng, Fan</creator><creator>Lv, Peng</creator><creator>Ma, Shangshang</creator><creator>Chen, Keping</creator><creator>Yao, Qin</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200320</creationdate><title>Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis</title><author>Ge, Qi ; Chen, Liang ; Yuan, Yi ; Liu, Lanlan ; Feng, Fan ; Lv, Peng ; Ma, Shangshang ; Chen, Keping ; Yao, Qin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-cea87316b16f8aa9495eeee1ea15c51735f1ab1729da9b533f82ed6b9eb464bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>active ingredients</topic><topic>anti-diabetic</topic><topic>anti-inflammatory</topic><topic>Lobelia chinensis</topic><topic>network pharmacology</topic><topic>Pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ge, Qi</creatorcontrib><creatorcontrib>Chen, Liang</creatorcontrib><creatorcontrib>Yuan, Yi</creatorcontrib><creatorcontrib>Liu, Lanlan</creatorcontrib><creatorcontrib>Feng, Fan</creatorcontrib><creatorcontrib>Lv, Peng</creatorcontrib><creatorcontrib>Ma, Shangshang</creatorcontrib><creatorcontrib>Chen, Keping</creatorcontrib><creatorcontrib>Yao, Qin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ge, Qi</au><au>Chen, Liang</au><au>Yuan, Yi</au><au>Liu, Lanlan</au><au>Feng, Fan</au><au>Lv, Peng</au><au>Ma, Shangshang</au><au>Chen, Keping</au><au>Yao, Qin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis</atitle><jtitle>Frontiers in pharmacology</jtitle><addtitle>Front Pharmacol</addtitle><date>2020-03-20</date><risdate>2020</risdate><volume>11</volume><spage>347</spage><epage>347</epage><pages>347-347</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>Diabetes mellitus (DM) is a chronic inflammatory disease, and the rapidly increasing DM is becoming a major problem of global public health. Traditional Chinese medicine (TCM) has a long history of treating diabetes. It has been developed and utilized because of its good efficacy and no toxic side effects. is a traditional whole grass herbal. With the continuous deepening of pharmacological research on TCM, the active ingredients of are continuously revealed, which contained the alkaloids, flavonoids, flavonoid glycosides and amino acids that have the good effects of anti-inflammatory, anti-viral and anti-diabetic. In order to further explore the targets of active ingredients and its anti-diabetic mechanism, a feasible network pharmacology analysis model based on chemical, pharmacokinetic and pharmacological data was developed by network construction method to clarify the anti-diabetic mechanism of . The present study conducted by gas chromatography-mass spectrometer (GC/MS), which identified 208 metabolites of , of which 23 ingredients may have effective pharmacological effects after absorption, distribution, metabolism, and excretion (ADME) screening. Network pharmacological analysis on the active ingredients revealed that 5-hydroxymethylfurfural in affects the insulin resistance signaling pathway by acting on GSK3B, TNF, and MAPK1, acacetin affects the diabetic pathway by acting on INSR, DPP4, and GSK3B, that regulate type 2 diabetes, non-insulin-dependent DM, and inflammatory diseases. These results successfully indicated the potential anti-diabetic mechanism of the active ingredients of .</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>32265717</pmid><doi>10.3389/fphar.2020.00347</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2020-03, Vol.11, p.347-347
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_eff47db032e544e89c27ebeb98f8008a
source PubMed Central
subjects active ingredients
anti-diabetic
anti-inflammatory
Lobelia chinensis
network pharmacology
Pharmacology
title Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T00%3A38%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Network%20Pharmacology-Based%20Dissection%20of%20the%20Anti-diabetic%20Mechanism%20of%20Lobelia%20chinensis&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Ge,%20Qi&rft.date=2020-03-20&rft.volume=11&rft.spage=347&rft.epage=347&rft.pages=347-347&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2020.00347&rft_dat=%3Cproquest_doaj_%3E2387691447%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-cea87316b16f8aa9495eeee1ea15c51735f1ab1729da9b533f82ed6b9eb464bd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2387691447&rft_id=info:pmid/32265717&rfr_iscdi=true